Publications en collaboration avec des chercheurs de Hospital Universitario de Basurto (28)

2023

  1. A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma

    Life, Vol. 13, Núm. 1

  2. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  3. Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

    Cancers, Vol. 15, Núm. 7

  4. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression

    Scientific Reports, Vol. 13, Núm. 1

  5. Ultrafast detection of β-lactamase resistance in Klebsiella pneumoniae from blood culture by nanopore sequencing

    Future microbiology, Vol. 18, pp. 1309-1317

2022

  1. Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

    Life, Vol. 12, Núm. 12

  2. Karbapenem motako antibiotikoekiko erresistentzien garapenean inplikatutako faktoreak

    Osagaiz: osasun-zientzien aldizkaria, Vol. 6, Núm. 1, pp. 67-80

2021

  1. Ultra-fast direct method for identifying microorganisms from BACTEC lytic/10 anaerobic/F flasks

    Future Microbiology, Vol. 16, Núm. 18, pp. 1381-1387

2020

  1. BRAF V600E mutational load as a prognosis biomarker in malignant melanoma

    PLoS ONE, Vol. 15, Núm. 3

2017

  1. RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection

    Virology Journal, Vol. 14, Núm. 1

2016

  1. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker

    BMC Cancer, Vol. 16, Núm. 1

  2. Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain

    BMC Public Health, Vol. 16, Núm. 1

2015

  1. Human papillomavirus 16 variants may be identified by E6 gene analysis

    Intervirology, Vol. 58, Núm. 3, pp. 143-148

2014

  1. The Interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a south European population

    PLoS ONE, Vol. 9, Núm. 8

2013

  1. Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic Hepatitis B virus infection

    Intervirology, Vol. 56, Núm. 3, pp. 190-194

2012

  1. Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain

    Virology Journal, Vol. 9

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

  2. Evolution of hepatitis b virus during long-term therapy in patients with chronic hepatitis B

    Annals of Hepatology, Vol. 10, Núm. 4, pp. 434-440

2010

  1. Monitoring of therapy in Patients with chronic hepatitis B virus

    European Journal of Gastroenterology and Hepatology, Vol. 22, Núm. 6, pp. 736-740

  2. The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79

    Human Heredity, Vol. 69, Núm. 1, pp. 34-44